AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML) Patrick P. Zarrinkar, Ruwanthi N. Gunawardane,et al. Blood 2009;114: 2984-2992
FLT3 inhibitors for the treatment of acute myeloid leukemia. Wiernik PH. Clin Adv Hematol Oncol. 2010 Jun;;8(6):429-44.
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.